Five Prime Therapeutics' Partnership - III Round

Five Prime Therapeutics raised a round of funding on May 24, 2010. Investors include National Multiple Sclerosis Society.

Five Prime Therapeutics is a clinical-stage biotechnology company with a pipeline of antibodies and ligand traps for cancer, autoimmunity and respiratory diseases. FivePrime has differentiated discove…

Articles about Five Prime Therapeutics' Partnership - III Round: